Myocardial metabolism and cardiac performance in obesity and insulin resistance

被引：24

作者：

Banerjee S. ^{[1
]}

Peterson L.R. ^{[1
]}

机构：

[1] Washington University School of Medicine, Department of Medicine, St. Louis, MO 63110

来源：

Current Cardiology Reports | 2007年 / 9卷 / 2期

基金：

美国国家卫生研究院;

关键词：

Insulin Resistance; Left Ventricular Diastolic Dysfunction; Left Ventricular Diastolic Function; Myocardial Metabolism; Myocardial Fatty Acid;

D O I：

10.1007/BF02938341

中图分类号：

学科分类号：

摘要：

Obesity, insulin resistance, and their frequent complication of type 2 diabetes are risk factors for left ventricular diastolic dysfunction, systolic dysfunction, and clinical heart failure. Although obesity, insulin resistance, and diabetes are risk factors for coronary artery disease, and hence ischemic cardiomyopathy-related heart failure, there is increasing evidence that these three risk factors are implicated in the development of cardiac dysfunction not related to epicardial coronary disease. There are several mechanisms by which this triad may cause cardiac dysfunction, including alterations in myocardial metabolism, which may initially be adaptations but evolve into maladaptive responses over time. Recent advances in our understanding of these mechanisms will aid in the development of novel therapies, including metabolic manipulations that could prevent and treat cardiac dysfunction in patients with obesity, insulin resistance, and diabetes. Copyright © 2007 by Current Medicine Group LLC.

引用

页码：143 / 149

页数：6

共 50 条

[1]

Flegal K.M., Carroll M.D., Ogden C.L., Johnson C.L., Prevalence and trends in obesity among US adults, 1999-2000, JAMA, 288, pp. 1723-1727, (2002)

[2]

Boyle J.P., Honeycutt A.A., Narayan K.M., Et al., Projection of diabetes burden through 2050: Impact of changing demography and disease prevalence in the US, Diabetes Care, 24, pp. 1936-1940, (2001)

[3]

Zimmet P., Alberti K.G., Shaw J., Global and societal implications of the diabetes epidemic, Nature, 414, pp. 782-787, (2001)

[4]

Yach D., Stuckler D., Brownell K.D., Epidemiologic and economic consequences of the global epidemics of obesity and diabetes, Nat Med, 12, pp. 62-66, (2006)

[5]

Kenchaiah S., Evans J.C., Levy D., Et al., Obesity and the risk of heart failure, N Engl J Med, 347, pp. 305-313, (2002)

[6]

Kannel W.B., Hjortland M., Castelli W.P., Role of diabetes in congestive heart failure: The Framingham study, Am J Cardiol, 34, pp. 29-34, (1974)

[7]

Hamby R.I., Zoneraich S., Sherman L., Diabetic cardiomyopathy, JAMA, 229, pp. 1749-1754, (1974)

[8]

Varela-Roman A., Grigorian Shamagian L., Barge Caballero E., Et al., Influence of diabetes on the survival of patients hospitalized with heart failure: A 12-year study, Eur J Heart Fail, 7, pp. 859-864, (2005)

[9]

Berkalp B., Cesur V., Corapcioglu D., Et al., Obesity and left vcntricular diastolic dysfunction, Int J Cardiol, 52, pp. 23-26, (1995)

[10]

Peterson L.R., Waggoner A.D., Schechtman K.B., Et al., Alterations in left ventricular structure and function in young healthy obese women: Assessment by echocardiography and tissue Doppler imaging, J Am Coll Cardiol, 43, pp. 1399-1404, (2004)

← 1 2 3 4 5 →